Developer docs
API playgroundTry for free, no card

Search company profiles

Tomocube

Full company profile

uuid0002lj4

Namestring
Tomocube
Legal namestring
Tomocube, Inc.
Websiteurl
tomocube.com
Company typeenum
Public
Founded yearint
2015
Descriptiontext

Tomocube, Inc. is a South Korea-based, KOSDAQ-listed (since November 2024) developer and manufacturer of holotomography (HT) microscopy systems and supporting AI-driven image analysis software. Founded in 2015 in Daejeon by KAIST physics professor YongKeun (Paul) Park, the company commercializes a label-free, non-invasive 3D imaging technique that reconstructs refractive index distributions from LED-based incoherent illumination to produce quantitative tomograms of live cells, tissues, and transparent industrial materials without staining or sample destruction. Its product portfolio spans the HT-X1 family of bioimaging instruments (the flagship HT-X1 Plus with integrated epifluorescence and spinning disk confocal modalities, the HT-X1, and the compact HT-X1 mini), the industrial metrology systems HT-T1 (transmission) and HT-R1 (reflection), and the TomoAnalysis software suite with AI-based segmentation and quantification modules.

The company's commercial model centers on hardware system sales as the primary revenue driver, complemented by a growing recurring revenue base from TomoAnalysis software subscriptions/licenses, HT-ready 96-well plates and accessories (consumables), and professional services. Pricing is quote-based across all product lines with multi-year contracts, and go-to-market is executed through wholly-owned direct sales subsidiaries in Korea (headquarters), the United States (San Diego, profitable in 2025 with approximately 4 billion KRW revenue), and Germany (Langen, established June 2025 with 8.6 billion KRW in its first year), plus dedicated sales leadership for Greater China appointed in April 2026. The company invests approximately 46% of revenue in R&D and holds more than 90 patents covering its core technology and AI applications.

Tomocube serves four primary verticals: academic and life science research institutions (cell biology, organoids, regenerative medicine, immunology, LLPS, stem cell research), pharmaceutical and biotechnology companies (drug discovery, organoid screening, cell therapy QC), semiconductor and display manufacturers using the Precision Division for non-destructive 3D metrology (launched September 2025), and emerging clinical applications such as IVF embryo assessment. Named customers and partners include KAIST, Johns Hopkins University, Institut Gustave Roussy, the NCI-led Human Tumor Atlas Network (HTAN), University of Lausanne, Okomera (droplet microfluidics integration), CrestOptics (spinning disk confocal integration), and an unnamed global pharmaceutical company under a joint development agreement. As of FY2025, Tomocube reported revenue of 113 billion KRW (up 90.4% year-over-year), with overseas revenue contributing 75.9% of the total and the company achieving its first quarterly operating profit in Q4 2025.

Short descriptiontext

Tomocube develops holotomography microscopy systems and AI-powered image analysis software that enable label-free, non-invasive 3D quantitative imaging of live cells and transparent materials. The company serves academic researchers, pharmaceutical and biotech firms, semiconductor manufacturers, and emerging clinical applications globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDaejeon, South Korea
HQ citystring
Daejeon
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D holotomography microscopy, label-free live cell imaging, refractive index tomography, quantitative bioimaging systems, semiconductor optical metrology
Industry1 code
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Surgical & Medical Instruments & Apparatus3841
Product category
3D Holotomography Microscopy and Bioimaging Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Holotomography Imaging Systems
TypeHardware Sales
Description

Sale of HT series hardware systems (HT-X1 Plus, HT-X1, HT-X1 mini, HT-T1, HT-R1) for life science research and industrial precision metrology. Primary revenue driver representing majority of company sales.

tomocube.com
2TomoAnalysis Software
TypeSubscription Recurring
Description

Image analysis software with AI-powered quantification and visualization. Subscription or license model for ongoing software updates and support. Recurring revenue stream growing as installed base expands.

tomocube.com
3Accessories and Consumables
TypeHardware Sales
Description

HT-ready 96 well plates, accessories, and consumables for HT systems. Expanding recurring revenue base through consumables sales.

tomocube.com
4Professional Services
TypeProfessional Services
Description

Technical support, training, installation, and customer development services. Part of comprehensive one-stop support system.

tomocube.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Full product lineup from entry-level to flagship systems
ModelOtherBilling cadenceMulti-year contract
Notes

HT-X1 mini (entry-level/accessible), HT-X1 (standard), HT-X1 Plus (flagship); HT-T1 and HT-R1 for industrial precision; TomoAnalysis software for data analysis. All pricing quote-based.

tomocube.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1HT-X1 Plus
Description

Flagship holotomography system with 4x larger field of view, 6x faster scanning, integrated epifluorescence and spinning disk confocal modalities, and AI-powered TomoAnalysis for high-throughput 3D bioimaging.

tomocube.com
+6 more records
Core offering1 text field

Tomocube designs, manufactures, and sells holotomography (HT) 3D imaging systems and accompanying AI-powered analysis software for label-free, non-invasive imaging of live cells and transparent industrial materials. The company's commercial portfolio spans life-science microscopy systems (HT-X1 Plus, HT-X1, HT-X1 mini) with the TomoAnalysis software suite, and industrial precision-metrology systems (HT-T1, HT-R1) for non-destructive semiconductor, glass substrate, and display inspection.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Full 96-well plate scanned in under 30 minutes with HT-X1 Plus
+5 more records
Product and service6 records
1HT-X1 Plus
CategoryHolotomography microscopy system
Description

Flagship holotomography live-cell 3D imaging system integrating second-generation holotomography with multimodal imaging (epifluorescence and spinning disk confocal). Designed for organoid, stem cell research, drug discovery, and regenerative medicine applications with automated AI-powered quantification.

2HT-X1
CategoryHolotomography microscopy system
Description

Second-generation holotomography microscope using incoherent LED light source with single-beam technique for mechanically stable, high-contrast label-free 3D imaging of live cells. Includes 40x 0.95 NA objective and integrated 4-channel fluorescence engine with multi-well plate compatibility.

3HT-X1 mini
CategoryHolotomography microscopy system
Description

Compact, accessible holotomography platform at one-third the size and weight of the flagship model. Modular design with upgrade options including stage-top incubator, 3-channel fluorescence, laser autofocus, and additional wavelengths, designed to broaden adoption among smaller labs, startups, educational institutions, and clinics.

4TomoAnalysis
CategoryBioimaging analysis software
Description

AI-powered 3D image visualization and analysis software suite for holotomography data. Uses module-based data processing with AI-based analysis models for cellular and subcellular structure quantification, with capabilities like the Data Manager Combine function for 4D analysis merging multiple datasets.

5HT-T1 Transmission Holotomography
CategoryIndustrial precision metrology system
Description

Transmission-based holotomography system for non-destructive 3D inspection of transparent industrial materials including glass substrates, waveguides, and optical elements. Delivers 161nm lateral resolution, 1.298μm axial resolution, and 10^-4 refractive index sensitivity.

6HT-R1 Reflection Holotomography
CategoryIndustrial precision metrology system
Description

World's first reflection-based holotomography system for non-destructive 3D inspection of opaque and transparent industrial samples including wafers, display panels, and semiconductor packages. Provides 130nm lateral resolution, 0.294μm axial resolution, and 0.1nm surface sensitivity.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-15
Description

Collaboration on integrated droplet-based microfluidics and holotomography workflow for patient-derived organoid drug screening. Okomera's droplet-based organoid culture combined with Tomocube's HT-X1 enables label-free, quantitative monitoring of chemotherapy response in patient-derived tumoroids. Demonstrates synergy between Tomocube imaging and Okomera's high-throughput screening platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-11-20
Description

Strategic collaboration to provide next-generation multimodal imaging platform. HT-X1 Plus integrates CrestOptics' spinning disk confocal technology with Tomocube's holotomography, creating first commercially available spinning-disk confocal holotomographic instrument. Enables high-resolution label-free 3D imaging combined with fluorescence-based detection for advanced biophysical imaging applications.

3Daejeon Technopark
Strategic tierMinorTypeGTM or Marketing Partner
Description

Daejeon Technopark signed trilateral MOU with Daejeon Metropolitan Government and BioCentury to connect local biotech companies with global investors and pharmaceutical partners. Tomocube among 11 Daejeon-based companies featured in investor relations pitching session alongside Eli Lilly, SBC Group, and Temasek. Part of Daejeon's positioning as global biotech investment hub.

koreaherald.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint development agreement for non-bio (industrial precision) applications of holotomography technology. Collaboration with a National Institutes of Health agency on Organoid research standardization.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Carl Zeiss Microscopy
TypeBroad incumbent
Description

Dominant incumbent in life science microscopy offering confocal, super-resolution, and light-sheet systems with deep installed base and global service. Comparable as a broad microscopy competitor whose R&D resources could incorporate label-free 3D imaging capabilities.

TypeBroad incumbent
Description

Major microscopy brand under Danaher's life sciences portfolio offering confocal, widefield, and advanced 3D imaging systems. Directly competes for the same academic and pharma imaging budgets as Tomocube with bundled multi-modal platforms.

3Nikon Instruments
TypeBroad incumbent
Description

Established Japanese microscopy and imaging provider serving life science, clinical, and industrial customers. Comparable as a multi-modality microscope vendor that competes for capital equipment budgets at universities and pharma.

TypeBroad incumbent
Description

Major microscopy and life science imaging brand (formerly Olympus) offering confocal and live-cell imaging systems. Comparable as a broad microscopy incumbent competing for the same cell biology and pharma imaging use cases as Tomocube.

TypeBroad incumbent
Description

Global scientific instruments company with a significant microscopy business covering super-resolution, AFM, and nano-analysis. Comparable as a research tools incumbent whose broad portfolio targets overlapping academic and biopharma customers.

TypeDirect peer
Description

Swiss-based startup offering label-free 3D live cell imaging using holotomography-like technology. The most direct comparable to Tomocube's life science product line, targeting similar academic and pharma customers with a competing label-free imaging approach.

TypeDirect peer
Description

Swedish company developing quantitative holographic imaging for label-free cell analysis and time-lapse monitoring. Direct competitor in the holotomography/holographic imaging niche with similar life science research applications.

TypeEmerging player
Description

Dutch live-cell imaging company providing compact, accessible microscopy systems for cell culture monitoring. Comparable as an emerging player focused on democratizing live-cell imaging for smaller labs and high-throughput workflows.

TypeBroad incumbent
Description

Global leader in semiconductor process control and yield management with dominant position in wafer inspection and metrology. Comparable as the incumbent Tomocube's Precision Division must compete against in semiconductor packaging and TGV inspection.

TypeRegional player
Description

Korean nano-metrology company and AFM leader with overlapping customer base in academic and industrial research. Comparable as a Korean-headquartered precision instruments peer that shares the same domestic market and some academic/government customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tomocube

3D Holotomography Microscopy and Bioimaging Systemstomocube.com

Tomocube develops holotomography microscopy systems and AI-powered image analysis software that enable label-free, non-invasive 3D quantitative imaging of live cells and transparent materials. The company serves academic researchers, pharmaceutical and biotech firms, semiconductor manufacturers, and emerging clinical applications globally.

What Tomocube does

Tomocube, Inc. is a South Korea-based, KOSDAQ-listed (since November 2024) developer and manufacturer of holotomography (HT) microscopy systems and supporting AI-driven image analysis software. Founded in 2015 in Daejeon by KAIST physics professor YongKeun (Paul) Park, the company commercializes a label-free, non-invasive 3D imaging technique that reconstructs refractive index distributions from LED-based incoherent illumination to produce quantitative tomograms of live cells, tissues, and transparent industrial materials without staining or sample destruction. Its product portfolio spans the HT-X1 family of bioimaging instruments (the flagship HT-X1 Plus with integrated epifluorescence and spinning disk confocal modalities, the HT-X1, and the compact HT-X1 mini), the industrial metrology systems HT-T1 (transmission) and HT-R1 (reflection), and the TomoAnalysis software suite with AI-based segmentation and quantification modules.

The company's commercial model centers on hardware system sales as the primary revenue driver, complemented by a growing recurring revenue base from TomoAnalysis software subscriptions/licenses, HT-ready 96-well plates and accessories (consumables), and professional services. Pricing is quote-based across all product lines with multi-year contracts, and go-to-market is executed through wholly-owned direct sales subsidiaries in Korea (headquarters), the United States (San Diego, profitable in 2025 with approximately 4 billion KRW revenue), and Germany (Langen, established June 2025 with 8.6 billion KRW in its first year), plus dedicated sales leadership for Greater China appointed in April 2026. The company invests approximately 46% of revenue in R&D and holds more than 90 patents covering its core technology and AI applications.

Tomocube serves four primary verticals: academic and life science research institutions (cell biology, organoids, regenerative medicine, immunology, LLPS, stem cell research), pharmaceutical and biotechnology companies (drug discovery, organoid screening, cell therapy QC), semiconductor and display manufacturers using the Precision Division for non-destructive 3D metrology (launched September 2025), and emerging clinical applications such as IVF embryo assessment. Named customers and partners include KAIST, Johns Hopkins University, Institut Gustave Roussy, the NCI-led Human Tumor Atlas Network (HTAN), University of Lausanne, Okomera (droplet microfluidics integration), CrestOptics (spinning disk confocal integration), and an unnamed global pharmaceutical company under a joint development agreement. As of FY2025, Tomocube reported revenue of 113 billion KRW (up 90.4% year-over-year), with overseas revenue contributing 75.9% of the total and the company achieving its first quarterly operating profit in Q4 2025.

Tomocube firmographics

Firmographics
Name
Tomocube
Legal name
Tomocube, Inc.
Website
https://tomocube.com
Company type
Public
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Tomocube develops holotomography microscopy systems and AI-powered image analysis software that enable label-free, non-invasive 3D quantitative imaging of live cells and transparent materials. The company serves academic researchers, pharmaceutical and biotech firms, semiconductor manufacturers, and emerging clinical applications globally.
Ownership category
akta.pro rank

Tomocube industry classification

Industry
Product category
3D Holotomography Microscopy and Bioimaging Systems
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • 3D holotomography microscopy
  • Label-free live cell imaging
  • Refractive index tomography
  • Quantitative bioimaging systems
  • Semiconductor optical metrology

Where Tomocube is headquartered

Location

Headquarters

HQ city
Daejeon
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

Tomocube business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Holotomography Imaging Systems: Sale of HT series hardware systems (HT-X1 Plus, HT-X1, HT-X1 mini, HT-T1, HT-R1) for life science research and industrial precision metrology. Primary revenue driver representing majority of company sales.
  2. TomoAnalysis Software: Image analysis software with AI-powered quantification and visualization. Subscription or license model for ongoing software updates and support. Recurring revenue stream growing as installed base expands.
  3. Accessories and Consumables: HT-ready 96 well plates, accessories, and consumables for HT systems. Expanding recurring revenue base through consumables sales.
  4. Professional Services: Technical support, training, installation, and customer development services. Part of comprehensive one-stop support system.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFull product lineup from entry-level to flagship systems

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Tomocube product offering

Product offering

Core offering

Tomocube designs, manufactures, and sells holotomography (HT) 3D imaging systems and accompanying AI-powered analysis software for label-free, non-invasive imaging of live cells and transparent industrial materials. The company's commercial portfolio spans life-science microscopy systems (HT-X1 Plus, HT-X1, HT-X1 mini) with the TomoAnalysis software suite, and industrial precision-metrology systems (HT-T1, HT-R1) for non-destructive semiconductor, glass substrate, and display inspection.

Differentiator

Problem solved

Functional benefit

Brands

  • HT-X1 Plus: Flagship holotomography system with 4x larger field of view, 6x faster scanning, integrated epifluorescence and spinning disk confocal modalities, and AI-powered TomoAnalysis for high-throughput 3D bioimaging.
  • HT-X1
  • HT-X1 mini
  • TomoAnalysis
  • HT-T1
  • HT-R1
  • Precision Division

Products and services

  • HT-X1 Plus Flagship holotomography live-cell 3D imaging system integrating second-generation holotomography with multimodal imaging (epifluorescence and spinning disk confocal). Designed for organoid, stem cell research, drug discovery, and regenerative medicine applications with automated AI-powered quantification.
  • HT-X1 Second-generation holotomography microscope using incoherent LED light source with single-beam technique for mechanically stable, high-contrast label-free 3D imaging of live cells. Includes 40x 0.95 NA objective and integrated 4-channel fluorescence engine with multi-well plate compatibility.
  • HT-X1 mini Compact, accessible holotomography platform at one-third the size and weight of the flagship model. Modular design with upgrade options including stage-top incubator, 3-channel fluorescence, laser autofocus, and additional wavelengths, designed to broaden adoption among smaller labs, startups, educational institutions, and clinics.
  • TomoAnalysis AI-powered 3D image visualization and analysis software suite for holotomography data. Uses module-based data processing with AI-based analysis models for cellular and subcellular structure quantification, with capabilities like the Data Manager Combine function for 4D analysis merging multiple datasets.
  • HT-T1 Transmission Holotomography Transmission-based holotomography system for non-destructive 3D inspection of transparent industrial materials including glass substrates, waveguides, and optical elements. Delivers 161nm lateral resolution, 1.298μm axial resolution, and 10^-4 refractive index sensitivity.
  • HT-R1 Reflection Holotomography World's first reflection-based holotomography system for non-destructive 3D inspection of opaque and transparent industrial samples including wafers, display panels, and semiconductor packages. Provides 130nm lateral resolution, 0.294μm axial resolution, and 0.1nm surface sensitivity.

Quantifiable outcome

  • Full 96-well plate scanned in under 30 minutes with HT-X1 Plus
  • +5 more outcomes

Companies that use Tomocube

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Tomocube technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature6 records

Tomocube partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • OkomeracoreStrategic or Co-development Partner · 15 October 2025Collaboration on integrated droplet-based microfluidics and holotomography workflow for patient-derived organoid drug screening. Okomera's droplet-based organoid culture combined with Tomocube's HT-X1 enables label-free, quantitative monitoring of chemotherapy response in patient-derived tumoroids. Demonstrates synergy between Tomocube imaging and Okomera's high-throughput screening platform.
  • CrestOptics S.p.A.coreTechnology or Integration · 20 November 2024Strategic collaboration to provide next-generation multimodal imaging platform. HT-X1 Plus integrates CrestOptics' spinning disk confocal technology with Tomocube's holotomography, creating first commercially available spinning-disk confocal holotomographic instrument. Enables high-resolution label-free 3D imaging combined with fluorescence-based detection for advanced biophysical imaging applications.
  • Daejeon TechnoparkminorGTM or Marketing PartnerDaejeon Technopark signed trilateral MOU with Daejeon Metropolitan Government and BioCentury to connect local biotech companies with global investors and pharmaceutical partners. Tomocube among 11 Daejeon-based companies featured in investor relations pitching session alongside Eli Lilly, SBC Group, and Temasek. Part of Daejeon's positioning as global biotech investment hub.
  • Global Pharmaceutical Company (unnamed)coreStrategic or Co-development PartnerJoint development agreement for non-bio (industrial precision) applications of holotomography technology. Collaboration with a National Institutes of Health agency on Organoid research standardization.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Tomocube competitors and assessment

Company assessment

Broad incumbents

  • Carl Zeiss Microscopy: Dominant incumbent in life science microscopy offering confocal, super-resolution, and light-sheet systems with deep installed base and global service. Comparable as a broad microscopy competitor whose R&D resources could incorporate label-free 3D imaging capabilities.
  • Leica Microsystems (Danaher): Major microscopy brand under Danaher's life sciences portfolio offering confocal, widefield, and advanced 3D imaging systems. Directly competes for the same academic and pharma imaging budgets as Tomocube with bundled multi-modal platforms.
  • Nikon Instruments: Established Japanese microscopy and imaging provider serving life science, clinical, and industrial customers. Comparable as a multi-modality microscope vendor that competes for capital equipment budgets at universities and pharma.
  • Evident (formerly Olympus Scientific Solutions): Major microscopy and life science imaging brand (formerly Olympus) offering confocal and live-cell imaging systems. Comparable as a broad microscopy incumbent competing for the same cell biology and pharma imaging use cases as Tomocube.
  • Bruker: Global scientific instruments company with a significant microscopy business covering super-resolution, AFM, and nano-analysis. Comparable as a research tools incumbent whose broad portfolio targets overlapping academic and biopharma customers.
  • KLA Corporation: Global leader in semiconductor process control and yield management with dominant position in wafer inspection and metrology. Comparable as the incumbent Tomocube's Precision Division must compete against in semiconductor packaging and TGV inspection.

Direct peers

  • Nanolive: Swiss-based startup offering label-free 3D live cell imaging using holotomography-like technology. The most direct comparable to Tomocube's life science product line, targeting similar academic and pharma customers with a competing label-free imaging approach.
  • Phase Holographic Imaging (PHI): Swedish company developing quantitative holographic imaging for label-free cell analysis and time-lapse monitoring. Direct competitor in the holotomography/holographic imaging niche with similar life science research applications.

Emerging players

  • CytoSMART (Axion BioSystems): Dutch live-cell imaging company providing compact, accessible microscopy systems for cell culture monitoring. Comparable as an emerging player focused on democratizing live-cell imaging for smaller labs and high-throughput workflows.

Regional players

  • Park Systems: Korean nano-metrology company and AFM leader with overlapping customer base in academic and industrial research. Comparable as a Korean-headquartered precision instruments peer that shares the same domestic market and some academic/government customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Tomocube social profiles

Digital presence

Tomocube compliance and trust

Trust signal

Compliance2 records

Tomocube financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tomocube leadership team

Management profile

Number of profiles

Profiles6 records

Tomocube subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Tomocube funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tomocube M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tomocube

What does Tomocube do?

Tomocube designs, manufactures, and sells holotomography (HT) 3D imaging systems and accompanying AI-powered analysis software for label-free, non-invasive imaging of live cells and transparent industrial materials. The company's commercial portfolio spans life-science microscopy systems (HT-X1 Plus, HT-X1, HT-X1 mini) with the TomoAnalysis software suite, and industrial precision-metrology systems (HT-T1, HT-R1) for non-destructive semiconductor, glass substrate, and display inspection.

Is Tomocube a public or private company?

Tomocube is a public company. It is classified as public and is currently operating.

When was Tomocube founded?

Tomocube was founded in 2015. It employs 51 to 100 people.

Where is Tomocube based?

Tomocube is headquartered in Daejeon, South Korea, in the Asia region.

How does Tomocube make money?

Four revenue lines are on record. Holotomography Imaging Systems are the primary driver. The others are tomoAnalysis Software, accessories and Consumables and professional Services.

Who are Tomocube's main competitors?

Broad incumbents on record are Carl Zeiss Microscopy, Leica Microsystems (Danaher), Nikon Instruments, Evident (formerly Olympus Scientific Solutions), Bruker and KLA Corporation. Direct peers are Nanolive and Phase Holographic Imaging (PHI). CytoSMART (Axion BioSystems) is listed as an emerging player. Park Systems is listed as a regional player.

Does Tomocube have an API?

No public API is recorded for Tomocube.

What industry is Tomocube in?

Tomocube's product category is 3D Holotomography Microscopy and Bioimaging Systems. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nate[Market Supply and Demand Capture] Tomocube, foreign investors have been net buyers for 5 consecutive days... stock price +2.62% : Nate NewsTomocube (stock code 475960) saw its stock price rise 2.62% to 33,350 won as of 10:15 on the 3rd, according to intraday market data. Foreign investors have been net buyers for five consecutive days, accumulating 24,316 shares during this period. The article provides real-time trading data capturing investor flow and price movement for the stock.Mirage NewsKAIST's IVF Tech Gains Global Conference RecognitionKAIST researchers, led by Dr. Chungha Lee, developed a holotomography-based technology that combines time-lapse imaging with quantitative three-dimensional analysis to non-invasively assess oocyte and embryo developmental potential for IVF procedures without damaging live cells. The technology was recognized with the Basic Science Award for poster presentation at the 2026 Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London. The research, conducted in collaboration with CHA Bundang Medical Center, Avenues, and Tomocube, demonstrates how AI analysis combined with 3D imaging can move beyond conventional qualitative embryo assessment methods toward more objective quantitative evaluation.Mirage NewsKAIST's IVF Tech Wins Acclaim at Global ConferenceKAIST researchers, led by Dr. Chungha Lee and Professor YongKeun Park, received the Basic Science Award at the 2026 ESHRE Annual Meeting in London for developing a holotomography-based technology that enables non-invasive 3D imaging and quantitative analysis of live oocytes and embryos to predict developmental potential. The technology, developed through an industry-academia-clinical collaboration involving CHA Bundang Medical Center, Tomocube, and Avenues, uses label-free light refraction imaging to overcome limitations of conventional 2D morphological assessment methods. The team is currently conducting validation studies using human oocytes with the aim of ultimately improving IVF success rates.The Manila TimesTomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced PackagingTomocube announced the launch of HT-T1 Desktop (HT-T1D), a desktop holotomography system designed for high-resolution 3D defect analysis of glass substrates used in next-generation semiconductor packaging, along with TAMI analysis software. The system enables non-destructive inspection that can resolve defect location, morphology, and depth characteristics, reducing defect-analysis cycles from days or weeks to minutes compared to traditional destructive failure analysis methods. Glass substrates are emerging as critical materials for AI accelerators, HBM, and advanced packaging applications, and the company aims to support manufacturers in accelerating yield learning and process improvements.BastillepostTomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced PackagingTomocube announced the launch of the HT-T1 Desktop, a holotomography system designed for high-resolution 3D defect analysis of glass substrates in advanced semiconductor packaging. The system utilizes non-destructive imaging to identify internal defects, aiming to accelerate yield learning and reduce analysis time from weeks to minutes. This release coincides with Emdoor's unveiling of its Ailyn AI hub at WAIC 2026, which integrates computing power across various devices.AijournTomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced PackagingTomocube announced the launch of HT-T1 Desktop, a desktop holotomography system for high-resolution 3D defect analysis of glass substrates used in next-generation semiconductor packaging, including AI accelerators and high-bandwidth memory applications. The system enables non-destructive visualization of internal defects with refractive-index sensitivity of 10⁻⁴, reducing defect-analysis cycles from days or weeks to minutes compared to traditional destructive failure analysis methods. Alongside the hardware, Tomocube introduced TomoAnalysis MI (TAMI) software, providing a unified workflow from R&D investigation through production-line review for glass-substrate manufacturers and advanced-packaging companies.Third NewsRevolutionizing Semiconductor Packaging: Tomocube's New HT-T1 Desktop SystemTomocube launched the HT-T1 Desktop (HT-T1D), a holotomography system for high-resolution 3D defect analysis in glass substrates used in advanced semiconductor packaging. The system compresses defect analysis timelines from days or weeks using traditional destructive testing to minutes, utilizing non-destructive visible-light technology with 10⁻⁴ sensitivity. The company plans to collaborate with glass substrate manufacturers and advanced packaging firms to drive innovation in defect analysis and yield improvement.PR Newswire APACTomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced PackagingTomocube announced the launch of HT-T1 Desktop, a desktop holotomography system for high-resolution 3D defect analysis of glass substrates used in next-generation semiconductor packaging for AI accelerators and HBM applications. The system uses visible-light holotomography to non-destructively visualize internal defects, reducing traditional defect-analysis cycles from days or weeks to minutes. Alongside the hardware, Tomocube introduced TAMI (TomoAnalysis MI) software to provide a unified workflow from R&D investigation through production-line review for glass-substrate manufacturers.Third NewsTomocube Unveils Groundbreaking HT-T1 Desktop for 3D Analysis of Glass SubstratesTomocube, a South Korean company specializing in non-destructive 3D inspection and metrology, has launched the HT-T1 Desktop (HT-T1D), a holotomography system designed for high-resolution 3D defect analysis of glass substrates used in semiconductor packaging. The system uses visible-light holotomography with refractive-index sensitivity of 10⁻⁴, enabling non-destructive, repeated measurements that can monitor defect development across production stages and significantly reduce analysis cycles compared to traditional destructive methods. Tomocube has also introduced complementary software called TomoAnalysis MI (TAMI) to provide quantitative 3D analysis and structured reporting for engineering reviews.Third NewsTomocube Unveils HT-T1 Desktop for Advanced 3D Defect Analysis of Glass SubstratesTomocube has launched the HT-T1 Desktop (HT-T1D), a holotomography system for non-destructive 3D analysis of glass substrates used in semiconductor packaging, specifically for applications like AI accelerators and High-Bandwidth Memory (HBM). The system can detect internal micro-defects that traditional automated optical inspection systems cannot, reducing analysis times from days or weeks to just minutes. Tomocube also introduced TAMI, a companion 3D analysis software platform designed to streamline inspection workflows and support integration with system integrators.